3 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Ovarian Cancer Survival Across the Introduction of Targeted Treatment: A Nationwide Analysis by Histotype and Stage
Background Bevacizumab was approved for targeted therapy of ovarian cancer in 2011 by the European Medicines Agency, with the subsequent introduction of PARP (poly[ADP]-ribose polymerase) inhibitors in 2014. Improvements in outcomes of cytoreductive surgery occurred in parallel in many regions. Objectives Population...
Trends in Pancreatic Cancer Mortality in Europe and the USA, 1990-2024, and Predictions to 2030
Introduction Pancreatic cancer is the fourth leading cause of cancer-related mortality in Europe, accounting for approximately 140,000 deaths in 2024. While mortality for many major cancers has declined over recent decades, pancreatic cancer did not decline and is characterized by a poor prognosis and high fatality ra...